| A high-throughput inhibition assay to study MERS-CoV antibody interactions using image cytometry O Rosen, LLY Chan, OM Abiona, P Gough, L Wang, W Shi, Y Zhang, ... Journal of virological methods 265, 77-83, 2019 | 13 | 2019 |
| A platform incorporating trimeric antigens into self-assembling nanoparticles reveals SARS-CoV-2-spike nanoparticles to elicit substantially higher neutralizing responses than … B Zhang, CW Chao, Y Tsybovsky, OM Abiona, GB Hutchinson, JI Moliva, ... Scientific reports 10 (1), 18149, 2020 | 117 | 2020 |
| An mRNA vaccine against SARS-CoV-2—preliminary report LA Jackson, EJ Anderson, NG Rouphael, PC Roberts, M Makhene, ... New England journal of medicine 383 (20), 1920-1931, 2020 | 3514 | 2020 |
| Anti-coronavirus antibodies and methods of use K WESTENDORF, S ZENTELIS, K MUTHURAMAN, K JEPSON, ... | | 2021 |
| Anti-coronavirus antibodies and methods of use K Westendorf, S Zentelis, K Muthuraman, K Jepson, E Falconer, ... US Patent 11,447,541, 2022 | | 2022 |
| Anti-coronavirus antibodies and methods of use K Westendorf, S Zentelis, K Muthuraman, K Jepson, E Falconer, ... US Patent 11,370,828, 2022 | | 2022 |
| Anti-Coronavirus Antibodies and Methods of Use K Westendorf, S Zentelis, K Muthuraman, K Jepson, E Falconer, ... US Patent App. 18/194,105, 2024 | | 2024 |
| Anti-Coronavirus Antibodies and Methods of Use K Westendorf, S Zentelis, K Muthuraman, K Jepson, E Falconer, ... US Patent App. 17/192,243, 2022 | | 2022 |
| Anti-Coronavirus Antibodies and Methods of Use K Westendorf, S Zentelis, K Muthuraman, K Jepson, E Falconer, ... US Patent App. 17/116,588, 2021 | 3 | 2021 |
| Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variants L Wang, T Zhou, Y Zhang, ES Yang, CA Schramm, W Shi, A Pegu, ... BioRxiv, 2021 | 27 | 2021 |
| Anticorps anti-coronavirus et procédés d'utilisation O Abiona, JS Boyles, Q Chai, K Corbett, J Davies, E Falconer, D Foster, ... | | 2021 |
| Baoshan Zhang1, 4, Cara W. Chao1, 4, Yaroslav Tsybovsky2, Olubukola M. Abiona1, Geoffrey B. Hutchinson1, Juan I. Moliva1, Adam S. Olia1, Amarendra Pegu1, Emily Phung1, 3 … NJ Sullivan, BS Graham, KS Corbett, PD Kwong1Ε Scientific Reports 10, 18149, 2020 | | 2020 |
| BASE ESTRUCTURAL PARA LA NEUTRALIZACIÓN POTENCIAL DE BETA-CORONAVIRUS POR ANTICUERPOS DE CAMÉLIDOS DE DOMINIO ÚNICO D Wrapp, D De Vlieger, KS Corbett, B Schepens, X Saelens, JS McLellan | | |
| Burden of dengue infection and disease in a pediatric cohort in urban Sri Lanka H Tissera, A Amarasinghe, AD De Silva, P Kariyawasam, KS Corbett, ... The American journal of tropical medicine and hygiene 91 (1), 132, 2014 | 42 | 2014 |
| Career advice from my father:“Go where you are loved” KS Corbett Molecular Biology of the Cell 32 (22), ae3, 2021 | | 2021 |
| Co-immunization with hemagglutinin stem immunogens elicits cross-group neutralizing antibodies and broad protection against influenza A viruses SM Moin, JC Boyington, S Boyoglu-Barnum, RA Gillespie, G Cerutti, ... Immunity 55 (12), 2405-2418. e7, 2022 | 16 | 2022 |
| COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge AT DiPiazza, SR Leist, OM Abiona, JI Moliva, A Werner, M Minai, ... Immunity 54 (8), 1869-1882. e6, 2021 | 76 | 2021 |
| Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation D Wrapp, N Wang, KS Corbett, JA Goldsmith, CL Hsieh, O Abiona, ... Science 367 (6483), 1260-1263, 2020 | 9848 | 2020 |
| Dengue type 1 viruses circulating in humans are highly infectious and poorly neutralized by human antibodies R Raut, KS Corbett, RN Tennekoon, S Premawansa, A Wijewickrama, ... Proceedings of the National Academy of Sciences 116 (1), 227-232, 2019 | 81 | 2019 |
| Dengue type 1 viruses circulating in humans are highly infectious and poorly neutralized by human antibodies. RR Rajendra Raut, KS Corbett, RN Tennekoon, S Premawansa, ... | | 2019 |
